SOP ICU-acquired Weakness (Critical-Illness-Polyneuropathie/Critical-Illness-Myopathie)

In dieser Rubrik stellen wir Standard Operating Procedures (SOPs) für häufige, intensivmedizinisch relevante Prozesse vor. Die Form ist eher im Sinne einer Schablone zu verstehen als – durchaus subjektiv gefärbte – Anregung, eigene, auf lokale Gegebenheiten adaptierte stationsinterne SOPs zu entwerfen und zu implementieren.

Playlist „SOPs Intensivmedizin up2date“

Alle SOPs auf einen Blick

In der Playlist „SOPs Intensivmedizin up2date“ haben wir für Sie alle bisher erschienenen SOPs übersichtlich zusammengestellt. Sie erreichen die Playlist über
https://eref.thieme.de/AEX8G

Publication History

Article published online:
27 May 2021

• Literatur

• 1 Kress JP, Hall JB. ICU-Acquired Weakness and Recovery from Critical Illness. N Engl J Med 2014; 370: 1626-1635 DOI: 10.1056/NEJMra1209390.
• 2 Brunkhorst F, Axer H. What are the Causes of and how do I treat critical Illness Neuropathy/Myopathy?. In: Deutschman CS, Neligan PJ. eds. Evidence-Based Practice of critical Care. 3rd ed.. Amsterdam: Elsevier; 2020: 208-214.e1
• 3 Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care 2015; 19: 274 DOI: 10.1186/s13054-015-0993-7.
• 4 Stevens RD, Dowdy DW, Michaels RK. et al. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 2007; 33: 1876-1891 DOI: 10.1007/s00134-007-0772-2.
• 5 Latronico N, Fenzi F, Recupero D. et al. Critical illness myopathy and neuropathy. Lancet 1996; 347: 1579-1582
• 6 De Jonghe B, Sharshar T, Lefaucheur J-P. et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002; 288: 2859-2867
• 7 Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011; 10: 931-941 DOI: 10.1016/S1474-4422(11)70178-8.
• 8 Fan E, Cheek F, Chlan L. et al. An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med 2014; 190: 1437-1446 DOI: 10.1164/rccm.201411-2011ST.
• 9 Hermans G, Clerckx B, Vanhullebusch T. et al. Interobserver agreement of Medical Research Council sum-score and handgrip strength in the intensive care unit. Muscle Nerve 2012; 45: 18-25 DOI: 10.1002/mus.22219.
• 10 Grimm A, Günther A, Witte OW. et al. Critical-Illness-Polyneuropathie und Critical-Illness-Myopathie. Med Klin Intensivmed Notfmed 2012; 107: 649-660 DOI: 10.1007/s00063-012-0186-y.
• 11 Lacomis D. Electrophysiology of neuromuscular disorders in critical illness. Muscle Nerve 2013; 47: 452-463 DOI: 10.1002/mus.23615.
• 12 Lefaucheur J-P, Nordine T, Rodriguez P. et al. Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatr 2006; 77: 500-506 DOI: 10.1136/jnnp.2005.070813.
• 13 Weber-Carstens S, Koch S, Spuler S. et al. Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med 2009; 37: 2632-2637 DOI: 10.1097/CCM.0b013e3181a92f28.
• 14 Bierbrauer J, Koch S, Olbricht C. et al. Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane. Crit Care Med 2012; 40: 647-650 DOI: 10.1097/CCM.0b013e31823295e6.
• 15 Grimm A, Teschner U, Porzelius C. et al. Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis. Crit Care 2013; 17: R227 DOI: 10.1186/cc13050.
• 16 Khan J, Harrison TB, Rich MM. et al. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 2006; 67: 1421-1425 DOI: 10.1212/01.wnl.0000239826.63523.8e.
• 17 Moss M, Yang M, Macht M. et al. Screening for critical illness polyneuromyopathy with single nerve conduction studies. Intensive Care Med 2014; 40: 683-690 DOI: 10.1007/s00134-014-3251-6.
• 18 Hermans G, De Jonghe B, Bruyninckx F. et al. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev 2014; (01) CD006832 DOI: 10.1002/14651858.CD006832.pub3.
• 19 Brunkhorst FM, Engel C, Bloos F. et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139 DOI: 10.1056/NEJMoa070716.
• 20 Brunner R, Rinner W, Haberler C. et al. Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial. Crit Care 2013; 17: R213 DOI: 10.1186/cc13028.